Table 1: Technical and clinical data of percutaenous mechanical circulatory support devices used for the treatment of cardiogenic shock.

 

iVAC® 2.0 L

Impella® 2.5 L

Impella® 5.0 L

Impella® 5.5 L

Impella® CP

V-A ECMO

Catheter Size (F)

11

9

9

9

9

 

Cannula Size (F)

17

12

21

19

14

14-19 arterial
17-21 venous

Maximum Flow (L/min)

2.0

2.5

5.0

6.0

4.3

7.0

Pump Mechanism

Pulsatile Flow - depend on HR

Axial flow - continuous pump

Axial flow - continuous pump

Axial flow - continuous pump

Axial flow - continuous pump

Centrifugal flow- continuous pump

Blood is aspirated from

Left Ventricle

Left Ventricle

Left Ventricle

Left Ventricle

Left Ventricle

Right Atrium

Blood is ejected in

Aorta

Ascending Aorta

Ascending Aorta

Ascending Aorta

Ascending Aorta

Aorta

Access Site

Femoral Artery

Femoral Artery

Femoral Artery
Axillary Artery

Axillary Artery

Femoral Artery

Femoral Vein

Femoral Artery

Implantation

Percutaneous

Percutaneous

Surgical

Percutaneous

Percutaneous

Percutaneous

LV Support

+

+

+

+

+

-

Indications

·         High-risk PCI

·         AcuteMyocardial Infarction

·         Cardiogenic shock

·         Left ventricular failure with an EF < 30%, and/or CI < 2.5 L/min/m2

·         Advnaced HF

·         Cardiogenic shock

·         Postcardiotomy cardiogenic shock

·         High-risk PCI

·         Cardiogenic shock

·         Postcardiotomy cardiogenic shock

 

·         Cardiogenic shock

·         Postcardiotomy cardiogenic shock

 

·         Advnaced HF

·         Cardiogenic shock

·         Postcardiotomy cardiogenic shock

·         High-risk PCI

 

Maximal duration of application

Up to 24 hours

Up to 4 days

Up to 14 days

Up to 14 days

Up to 4 days

 

Cost

+ +

++ +

++++

++++

++++

+ (+)

F: French; LV: Left Ventricle; L: Liter; Min: Minutes; HR: Heart Rate; HF: Heart Failure; PCI: Percutaneous Coronary Intervention; EF: Ejection Fraction; CI: Cardiac Index